Seahorse Bioscience and Moffitt Cancer Center Collaborate to Develop Method for Measuring Metabolism of 3D Microtissue

Billerica, MA -– Seahorse Bioscience and the Moffitt Cancer Center have announced that they have received an SBIR contract through the National Cancer Institute, to develop a reproducible method that will enable the measurement of metabolism of 3D microtissue, and can be used for high-throughput metabolic and pre-clinical toxicity screens. Cancer cells switch their metabolic [...]

OGT initiates clinical trial of array-based Non-Invasive Prenatal Test

Oxford Gene Technology (OGT), the molecular genetics company, today announced it is initiating a clinical trial of a new microarray-based non-invasive prenatal test (NIPT) for Down’s syndrome. OGT has developed proprietary microarray technology which has significant advantages over next generation sequencing (NGS). Time to result is reduced from up to ten days to less than [...]

BioTek Instruments Awarded Patent for Automated Ultrasonic Blockage Detection and Cleaning in Microplate Washers

WINOOSKI VT, USA — BioTek has been awarded U.S. Patent 8,858,718, covering the use of ultrasonic devices to check for clogged manifold tubes and to clean the manifold tubes of a microplate washer automatically. The two features are known as Verify™ and Ultrasonic Advantage™ and are available in BioTek’s 405 family of microplate washers. Using [...]

BIOTOOLS PRESIDENT NAMED FELLOW OF SAS.

Jupiter, FL - Dr.Rina K Dukor, President of BioTools, Inc., of Jupiter Florida, has recently been nominated and elected to the recognition of a Fellow of the Society For Applied Spectroscopy (SAS). The selection was based on the significant contributions, understanding and promotion of spectroscopic techniques of vibrational circular dichroism and Raman optical activity demonstrated [...]

Dow Chemical Licenses Simulations Plus Software to Assist with Toxicology and Environmental Research

LANCASTER, Calif. -- Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for discovery and development, announced that The Dow Chemical Company (NYSE: DOW) has licensed both its best-in-class GastroPlus™ and ADMET Predictor™ software programs. John DiBella, vice president of marketing and sales for Simulations Plus, said, “Dow again demonstrates its foresight by incorporating [...]

Cellular Dynamics Awarded $1.2 Million NEI Contract for Developing Patient-derived Stem Cells in Gear-up for Age-related Macular Degeneration Trial

MADISON, WIS.-— Cellular Dynamics International (CDI; Nasdaq: ICEL), today announced that the National Eye Institute (NEI), a division of the National Institutes of Health (NIH), awarded the company a $1.2 million contract to manufacture clinically compatible induced pluripotent stem cells (iPSCs) and iPSC-derived human retinal pigment epithelial (RPE) cells. These cells will be manufactured from [...]

Simulations Plus Adds to Portfolio with Release of MembranePlus

LANCASTER, Calif. -- Simulations Plus, Inc. (SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that it has expanded its product portfolio with the release of version 1.0 of its MembranePlus™ simulation software. Mr. John DiBella, vice president for marketing and sales of Simulations Plus, said, “Simulations Plus [...]

Synthetic Genomics Inc. Appoints Oliver Fetzer, Ph.D., MBA as Chief Executive Officer

LA JOLLA, CA -- Synthetic Genomics, Inc. (SGI), a synthetic biology company commercializing genomic technologies to revolutionize several industries, today announced the appointment of Oliver Fetzer, Ph.D., MBA as the company's new Chief Executive Officer (CEO). In his role as CEO Fetzer will also be a member of SGI's Board of Directors. Founding CEO, J. [...]

Breakthrough Method to Permit Quantification of Thousands of Proteins in Needle Biopsy Samples in 12 hours

SOUTH EASTON, Mass. -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a worldwide leader in the development and sale of high pressure-based sample preparation systems to the life sciences research market, today announced that Professor Ruedi Aebersold and his team presented a novel, accurate, highly reproducible, and robust method to allow – for [...]

Biognosys’ Spectronaut™ software now supports Thermo Scientific™ Proteome Discoverer™ platform

Zurich-Schlieren (CH) – Biognosys AG, a Swiss Proteomics Company, announced today the new release of its Spectronaut™ software for analysis of Hyper Reaction Monitoring (HRM) data that will now support spectral library generation from the Thermo Scientific™ Proteome Discoverer™ platform. From August 2013 Spectronaut™ software supports the analysis of DIA data generated on the Thermo [...]

Access IBO on Knowledge Center